Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

FMO6 Inhibitors

The chemical class denoted as FMO6 Inhibitors represents a collection of compounds meticulously designed to selectively target FMO6, an isoform of the flavin-containing monooxygenase (FMO) enzyme family. Flavin-containing monooxygenases play a crucial role in xenobiotic metabolism, particularly in the oxidative detoxification of various endogenous and exogenous compounds. FMO6, as a specific isoform within this family, is the subject of active research in biochemistry and pharmacology to elucidate its unique substrate preferences and regulatory mechanisms. Inhibitors within the FMO6 Inhibitors class are intricately engineered molecules with the primary goal of modulating the activity or function of FMO6, thereby inducing an inhibitory effect. Researchers in this field utilize a multifaceted approach, integrating insights from structural biology, medicinal chemistry, and computational modeling to unravel the complex molecular interactions between the inhibitors and the target FMO6.

Structurally, FMO6 Inhibitors are characterized by specific molecular features designed to facilitate selective binding to FMO6. This selectivity is crucial to minimize unintended effects on other FMO isoforms or cellular components, ensuring a focused impact on the intended molecular target. The development of inhibitors within this chemical class involves a comprehensive exploration of structure-activity relationships, optimization of pharmacokinetic properties, and a deep understanding of the molecular mechanisms associated with FMO6. As researchers delve deeper into the functional aspects of FMO6 Inhibitors, the knowledge generated contributes not only to deciphering the specific roles of flavin-containing monooxygenase 6 but also to advancing our broader comprehension of drug metabolism, xenobiotic detoxification, and the intricate regulatory networks involved in cellular processes. The exploration of FMO6 Inhibitors stands as a significant avenue for expanding fundamental knowledge in biochemistry and pharmacology.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Methimazole

60-56-0sc-205747
sc-205747A
10 g
25 g
$70.00
$112.00
4
(0)

It may act as a competitive inhibitor by binding to the enzyme's active site, thus preventing the enzyme from metabolizing substrates.

Chlorpromazine

50-53-3sc-357313
sc-357313A
5 g
25 g
$61.00
$110.00
21
(1)

It could bind non-competitively and alter the enzyme's conformation, reducing its activity.

Imidazole

288-32-4sc-204776
sc-204776A
sc-204776B
sc-204776C
25 g
100 g
1 kg
5 kg
$27.00
$56.00
$84.00
$343.00
2
(2)

As a structural analog to part of the FMO's active site, imidazole might inhibit the enzyme by competing with substrates.

Quinidine

56-54-2sc-212614
10 g
$104.00
3
(1)

By binding to the enzyme, quinidine could affect the enzyme's ability to metabolize its usual substrates.

Ketoconazole

65277-42-1sc-200496
sc-200496A
50 mg
500 mg
$63.00
$265.00
21
(1)

It may inhibit the enzyme by interacting with the heme group in the active site of the enzyme.

Cimetidine

51481-61-9sc-202996
sc-202996A
5 g
10 g
$62.00
$86.00
1
(1)

It may act as an inhibitor by binding to the active site and preventing substrate access.

Indole-3-carbinol

700-06-1sc-202662
sc-202662A
sc-202662B
sc-202662C
sc-202662D
1 g
5 g
100 g
250 g
1 kg
$39.00
$61.00
$146.00
$312.00
$1032.00
5
(1)

As a competitive inhibitor, it might interfere with substrate binding, reducing enzyme activity.